Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-330-375"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20120614.22.4-330-375"2
lpv:hasSubsequent	lp_eu:2012-06-14-Speech-4-330-4372
lpv:speaker	lp:Roberta Angelilli2
lpv:spokenAs	member_of_the_bureau; EPP (2009-07-21--2014-06-30)3 vice-president; European Parliament (2012-01-18--2014-06-30)3 substitute; EMPL (2012-01-19--2014-06-30)3 substitute; FEMM (2012-01-19--2014-06-30)3 member; Parliament's Bureau (2012-01-18--2014-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-15)3 member; LIBE (2012-01-19--2014-06-30)3 member; Delegation for relations with Afghanistan (2009-09-16--2014-06-30)3 substitute; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (2009-09-16--2014-06-30)3 substitute; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2010-03-18--2014-06-30)3
lpv:translated text	"Thousands of women have received prosthetic implants the contents of which are not suitable for medical use and could be damaging. These women have entrusted their health (and their money) to the company, unaware that industrial silicon had fraudulently been put into the implants. On 3 June 2012 the French agency responsible for medical equipment published data on the statements of problems in women with PIP breast implants (around 30 000 in France). The figures are as follows: - rupture of implants: 2 252, - inflammatory reaction: 1 380 women, - removals: 7 868, of which 5 257 were for preventative reasons. In Italy, from the data supplied by the Ministry for Health, 121 recovery and care units and 48 outpatient units said they had used PIP implants out of a total of 3 911 implant procedures. That an incident like this could occur is a very serious matter. We are talking about the health of our citizens. It must be an absolute priority. We need to subject materials used in medicine to stricter controls, improve quality and safety and restore patient confidence. This can only happen with a clear, certain and strengthened legal framework."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph